Rare Disease Day

Rare Disease Day is an international observance held on the last day of February to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. The day was established by the European Organisation for Rare Diseases (EURORDIS) and was first observed on February 29, 2008, a rare date that occurs only once every four years.

History

Rare Disease Day was initiated by EURORDIS and its Council of National Alliances. The first Rare Disease Day was celebrated in 2008 in Europe and Canada. Since then, it has grown to include participation from over 100 countries worldwide. The day aims to bring together patients, families, caregivers, medical professionals, researchers, and policymakers to advocate for better research, diagnosis, and treatment of rare diseases.

Objectives

The primary objectives of Rare Disease Day are to:

• Raise awareness among the general public and decision-makers about rare diseases and their impact on patients' lives.
• Advocate for policies that improve the lives of people living with rare diseases.
• Promote research and development of new treatments and therapies.
• Foster international collaboration and partnerships in the field of rare diseases.

Activities

Various activities are organized globally to mark Rare Disease Day, including:

• Conferences and seminars to discuss the latest research and developments in rare diseases.
• Fundraising events to support research and patient organizations.
• Social media campaigns to spread awareness and share personal stories of those affected by rare diseases.
• Educational programs in schools and communities to inform people about rare diseases.

Symbol

The symbol of Rare Disease Day is a logo featuring a hand with multi-colored stripes, representing the diversity of rare diseases and the solidarity of the rare disease community.

Impact

Rare Disease Day has significantly contributed to increased awareness and understanding of rare diseases. It has led to the establishment of national plans and strategies for rare diseases in several countries, increased funding for research, and improved access to diagnosis and treatment for patients.

See also

• Rare disease
• EURORDIS
• Orphan drug
• Genetic disorder
• Patient advocacy